Efficacy of an Oral Melatonin Suspension in Idiopathic Nocturnal Irritability among Infants Older than 6 Months: A Randomized, Single-blind, Quasi-experimental Trial
Abstract
Objective: Excessive or frequent night waking in infants can cause significant parental distress, maternal fatigue, family dysfunction, and increased risk of depression and anxiety. Melatonin, a hormone secreted in response to darkness, regulates the sleep-wake cycle. Infants with sleep difficulties may have low melatonin levels; therefore, melatonin supplementation may help improve sleep. This study evaluated the efficacy of an oral melatonin suspension in infants with idiopathic nocturnal irritability.
Methods: In this randomized, single-blind quasi-experimental clinical trial, infants aged 6-24 months with idiopathic nocturnal restlessness were assigned to receive either oral melatonin (0.1 mg/kg nightly) or a matching placebo for 14 days. Sleep parameters were recorded by parents at baseline and reassessed after treatment. Infants with organic causes of restlessness, sedative medication use, hypersensitivity, or poor adherence were excluded. Data were analyzed using appropriate statistical tests with a significance level of P < 0.05.
Findings: Sixty-seven infants were enrolled; 60 completed the study (30 melatonin and 30 placebo). After 14 days, the melatonin group showed significant reductions in nocturnal awakenings, sleep onset latency, and total nocturnal wakefulness, along with significant increases in longest continuous sleep duration and total sleep time. No significant changes occurred in the placebo group.
Conclusion: Melatonin at 0.1 mg/kg appears to be…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.